Gad Cotter Selected Research

Hemoglobins (Hemoglobin)

2/2016	Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients.
5/2013	The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure.
10/2012	The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries.
1/2008	Clinical and hemodynamic effects of bosentan dose optimization in symptomatic heart failure patients with severe systolic dysfunction, associated with secondary pulmonary hypertension--a multi-center randomized study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gad Cotter Research Topics

Disease

128	Heart Failure 05/2024 - 01/2003
17	Renal Insufficiency (Renal Failure) 01/2023 - 04/2009
14	Dyspnea (Shortness of Breath) 10/2022 - 07/2003
8	Cardiogenic Shock 02/2024 - 06/2002
8	Inflammation (Inflammations) 01/2023 - 03/2012
7	Weight Loss (Weight Reduction) 05/2024 - 05/2013
6	Myocardial Infarction 10/2022 - 01/2003
6	Heart Diseases (Heart Disease) 11/2017 - 10/2013
5	Atrial Fibrillation 01/2016 - 11/2003
3	Disease Progression 01/2021 - 10/2010
3	Edema (Dropsy) 01/2020 - 01/2014
3	Hypotension (Low Blood Pressure) 11/2019 - 07/2003
3	Body Weight (Weight, Body) 01/2019 - 01/2008
3	Diabetes Mellitus 10/2017 - 10/2012
3	Hypertension (High Blood Pressure) 05/2014 - 07/2004
3	Acute Coronary Syndrome 07/2003 - 09/2001
2	Vomiting 10/2022 - 07/2003
2	Nausea 10/2022 - 07/2003
2	Shock 09/2021 - 01/2008
2	Respiratory Sounds (Crackle) 02/2016 - 07/2014
2	Anemia 05/2013 - 10/2012
2	Seizures (Absence Seizure) 03/2012 - 10/2010
2	Stroke (Strokes) 03/2012 - 07/2004
2	Left Ventricular Dysfunction 01/2008 - 03/2006
2	Infarction (Infarctions) 05/2007 - 12/2003
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 05/2006 - 07/2004
2	Pulmonary Edema 08/2003 - 01/2003
1	Pain (Aches) 10/2022
1	Critical Illness (Critically Ill) 01/2022
1	Neoplasms (Cancer) 01/2021
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Alcoholic Fatty Liver 01/2020
1	Bone Fractures (Bone Fracture) 01/2020
1	Fibrosis (Cirrhosis) 01/2020

Drug/Important Bio-Agent (IBA)

16	rolofyllineIBA 01/2018 - 10/2008
15	RelaxinIBA 01/2023 - 04/2009
14	DiureticsIBA 04/2024 - 01/2008
13	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2023 - 08/2005
13	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2013
11	CreatinineIBA 01/2022 - 01/2012
7	Purinergic P1 Receptor AntagonistsIBA 01/2018 - 01/2010
7	Urea (Carbamide)FDA LinkGeneric 01/2017 - 08/2005
6	pro-brain natriuretic peptide (1-76)IBA 03/2024 - 11/2019
5	tezosentanIBA 01/2017 - 01/2003
5	NitrogenIBA 01/2017 - 08/2005
5	Adenosine (Adenocard)FDA LinkGeneric 03/2012 - 10/2008
4	SodiumIBA 05/2024 - 01/2014
4	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 04/2024 - 11/2014
4	Furosemide (Lasix)FDA LinkGeneric 01/2022 - 07/2003
4	Glucose (Dextrose)FDA LinkGeneric 04/2021 - 02/2008
4	Natriuretic PeptidesIBA 01/2019 - 01/2017
4	TroponinIBA 01/2017 - 11/2005
4	Adenosine A1 ReceptorIBA 11/2016 - 10/2008
4	Hemoglobins (Hemoglobin)IBA 02/2016 - 01/2008
4	Troponin T (Troponin T1)IBA 01/2016 - 11/2011
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2006 - 04/2003
3	C-Reactive ProteinIBA 01/2022 - 02/2016
3	LigandsIBA 02/2018 - 03/2015
3	salicylhydroxamic acid (SHAM)IBA 11/2017 - 02/2016
3	Vasodilator Agents (Vasodilators)IBA 12/2009 - 04/2004
2	IstaroximeIBA 01/2023 - 10/2022
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 01/2022
2	Lactic Acid (Lactate)FDA LinkGeneric 10/2022 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2021
2	AdrenomedullinIBA 09/2021 - 01/2020
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 04/2021 - 03/2015
2	Endothelin-1 (Endothelin 1)IBA 12/2020 - 08/2005
2	Growth Differentiation Factor 15IBA 11/2019 - 11/2015
2	Sar-Arg-Val-Tyr-Ile-His-Pro-Ala-OHIBA 02/2018 - 03/2015
2	Type 1 Angiotensin ReceptorIBA 02/2018 - 08/2017
2	MicroRNAs (MicroRNA)IBA 12/2016 - 01/2016
2	NitratesIBA 10/2016 - 10/2013
2	AlbuminsIBA 01/2016 - 01/2014
2	Nitric Oxide Synthase (NO Synthase)IBA 05/2007 - 07/2003
2	Dobutamine FDA LinkGeneric 03/2006 - 11/2005
2	Endothelins (Endothelin)IBA 08/2004 - 01/2003
2	cyclopropapyrroloindoleIBA 07/2004 - 08/2003
2	Glycoproteins (Glycoprotein)IBA 04/2003 - 09/2001
1	sacubitril and valsartan sodium hydrate drug combinationIBA 05/2024
1	ThiazidesIBA 04/2024
1	Acetazolamide (Diamox)FDA LinkGeneric 04/2024
1	xylometazoline (stas)IBA 04/2024
1	Enalaprilat (Vasotec)FDA LinkGeneric 12/2023
1	Carvedilol (Coreg)FDA LinkGeneric 12/2023
1	Enalapril FDA LinkGeneric 12/2023
1	Mineralocorticoid Receptor AntagonistsIBA 01/2023
1	antineoplaston A10 (A 10)IBA 01/2023
1	Nitroglycerin (Dynamite)FDA LinkGeneric 12/2021
1	IvabradineIBA 04/2021
1	Neprilysin (Neutral Endopeptidase)IBA 04/2021
1	Galectin 3 (LGALS3)IBA 01/2021
1	Insulin (Novolin)FDA Link 01/2020

Therapy/Procedure

45	Therapeutics 05/2024 - 09/2001
22	Patient Readmission 03/2024 - 02/2004
16	Length of Stay 01/2023 - 01/2010
3	Percutaneous Coronary Intervention 01/2006 - 09/2001
2	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2023 - 03/2017
2	Injections 12/2020 - 09/2010
2	Intravenous Infusions 01/2019 - 01/2013
2	Electric Countershock (Cardioversion) 01/2016 - 11/2003